IndiaTickerOrchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026BSE · exchange filing · pdf
Source filing Company dossier
Orchid Pharma
NSE:ORCHPHARMA · ISIN INE191A01027
- Close
- ₹1,001.45 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Orchid Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Updates - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Intimation Regarding Investor RoadshowBSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Amendment to AOA/MOA - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Updates - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Orchid Pharma LimitedNSE · financial results · pdf
Archived filing Record Date - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Corporate Action For Fixation Of Record DateBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Intimation Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ("SEBI Listing Regulations").BSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ('Amalgamating Company') With Orchid Pharma Limited ('Amalgamated Company/Company') And Their Respective Shareholders
And Creditors ('The Scheme') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 '(SEBI Listing Regulations)', As Amended.BSE · exchange filing · pdf
Source filing Press Release - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Trading Window - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing General Updates - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited And Orchid Pharma LimitedBSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (''''Amalgamating Company'''') With Orchid Pharma Limited (''''Amalgamated Company'''') And Their Respective Shareholders And Creditors (''''The Scheme'''') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Updates - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Orchid Pharma LimitedNSE · conference call · pdf
Source filing Orchid Pharma Ltd - 524372 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Orchid Pharma LimitedNSE · conference call · pdf
Source filing Investor Presentation - Orchid Pharma LimitedNSE · investor presentation · pdf
Source filing Orchid Pharma Ltd - 524372 - Appointment Of Internal Auditor Of The CompanyBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Statement Of Deviation Or Variation For The Quarter And Financial Year Ended On March 31, 2026BSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Board Meeting Outcome For Outcome Of Board Meeting For Considering And Approving Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31, 2026BSE · financial results · pdf
Source filing Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Considering And Approving Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31, 2026.BSE · financial results · pdf
Source filing Outcome of Board Meeting - Orchid Pharma LimitedNSE · financial results · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Change in Auditors - Orchid Pharma LimitedNSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter-IV And Financial Year Ended On March 31, 2026BSE · financial results · pdf
Source filing